Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor… - International journal of …, 2015 - Elsevier
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …
被引用次数：57 相关文章

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor… - International Journal of …, 2015 - infona.pl
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …
[PDF] jvsmedicscorner.com

[PDF][PDF] Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor, AA Udy… - 2014 - jvsmedicscorner.com
abstract The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor, AA Udy… - 2015 - pubmed.ncbi.nlm.nih.gov
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor… - International …, 2015 - research.monash.edu
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus …

JA Jamal, MBMN Mohd-Basri Mat-Nor… - 2015 - cabidigitallibrary.org
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

[引用][C] Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion …

JA Jamal, MB Mat-Nor… - International …, 2015 - espace.library.uq.edu.au
Here we describe the pharmacokinetics of piperacillin administered by continuous infusion
(CI) versus intermittent bolus (IB) dosing in critically ill patients receiving continuous …

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor… - International Journal …, 2014 - europepmc.org
The objective of this study was to describe the pharmacokinetics of meropenem,
administered by continuous infusion (CI) or intermittent bolus (IB), in critically ill patients …

[引用][C] Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion …

JA Jamal, MB Mat-Nor, FS Mohamad-Nor, AA Udy… - 2015